© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to February
CRBN-based GSPT1 molecular glue degrader
intravenous agent in Ph. I for AML + MDS
from phenotypic screen of CRBN mod library
J. Med. Chem., Feb. 16, 2021
Celgene/Bristol Myers Squibb, San Diego, CA
1. The Bristol Myers Squibb (BMS)/Celgene GSPT1 degrader (CC-90009) is a CRBN-based molecular glue (CELMoD). It is a clinical candidate in Ph. I for AML and MDS, and in…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.